scholarly journals Molecular Insights into the Assembly and Functional Diversification of Typhoid Toxin

mBio ◽  
2022 ◽  
Author(s):  
Xiaoyu Liu ◽  
Zhe Chen ◽  
Xuyao Jiao ◽  
Xukai Jiang ◽  
Jicheng Qiu ◽  
...  

Typhoid fever is a devastating disease that kills more than 115,000 people every year and is caused by Salmonella Typhi. Typhoid toxin, exclusively produced by S .

1927 ◽  
Vol 23 (12) ◽  
pp. 1288-1288

Having applied an intradermal test with typhoid toxin in a significant number of patients suffering from both typhoid fever and other acute febrile illnesses, Alisov and Morozkin came to the conclusion that this reaction is diagnostically equivalent to Widala's reaction, surpassing the latter in the speed of detection and greater technical simplicity.


2020 ◽  
Vol 88 (10) ◽  
Author(s):  
Xuyao Jiao ◽  
Sarah Smith ◽  
Gabrielle Stack ◽  
Qi Liang ◽  
Allan Bradley ◽  
...  

ABSTRACT Typhoid toxin is a virulence factor of Salmonella enterica serovar Typhi, the causative agent of typhoid fever, and is thought to be responsible for the symptoms of severe disease. This toxin has a unique A2B5 architecture with two active subunits, the ADP ribosyl transferase PltA and the DNase CdtB, linked to a pentameric B subunit, which is alternatively made of PltB or PltC. Here, we describe the generation and characterization of typhoid toxin-neutralizing human monoclonal antibodies by immunizing genetically engineered mice that have a full set of human immunoglobulin variable region genes. We identified several monoclonal antibodies with strong in vitro and in vivo toxin-neutralizing activity and different mechanisms of toxin neutralization. These antibodies could serve as the basis for the development of novel therapeutic strategies against typhoid fever.


2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Reena Thakur ◽  
Preeti Pathania ◽  
Navneet Kaur ◽  
Vattan Joshi ◽  
Kanthi Kiran Kondepudi ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Reena Thakur ◽  
Preeti Pathania ◽  
Navneet Kaur ◽  
Vattan Joshi ◽  
Kanthi Kiran Kondepudi ◽  
...  

AbstractTyphoid fever caused by Salmonella enterica serovar Typhi (S.Typhi) continues to be a major problem, especially in developing countries. Due to the rapid emergence of multi-drug-resistant (MDR) strains, which limits the efficacy of conventional antibiotics as well as problems associated with the existing vaccines, efforts are being made to develop effective prophylactic agents. CdtB subunit of typhoid toxin was selected for assessing its vaccine potential due to its high conservation throughout the Typhi strains. In-vitro assessment of DNase activity of cloned and purified CdtB protein showed a significant decrease in the band intensity of DNA. The measure of metabolic activity and morphological alterations assessed using different cell lines in the presence of CdtB protein showed no significant signs of toxicity. These observations were further strengthened by cell cycle analysis, assessed by flow cytometry. Keeping these observations in mind, the immunoprotective potential of CdtB was assessed using S.Typhi induced mouse peritonitis model. A significant titer of IgG antibodies (>128000) against CdtB protein was recorded in the immunized mice by enzyme-linked immunosorbent assay (ELISA), which was also validated by immunoblotting. Active immunization with the protein protected 75% mice against a lethal dose of S.Typhi Ty2. The data indicated a significant (up to 5 log) reduction in the bacterial load in the spleen and liver of immunized-infected mice compared to control (unimmunized-infected) mice which might have resulted in the modulation of histoarchitecture of spleen and liver and the levels of cytokines (IL-6, TNF-α and IL-10) production; thereby indicating the effectiveness of the subunit. The observations deduced from the study give the proof of concept of immunogenic potential of protein. However, further studies involving the immunoreactivity of CdtB with the statistically significant number of sera samples obtained from the human patients would be helpful in establishing the relevance of CdtB protein in humans and for making the strategies to develop it as an effective vaccine candidate.


2019 ◽  
Vol 25 (7) ◽  
pp. 1082-1088 ◽  
Author(s):  
Malick M. Gibani ◽  
Elizabeth Jones ◽  
Amber Barton ◽  
Celina Jin ◽  
Juliette Meek ◽  
...  
Keyword(s):  

2016 ◽  
Vol 113 (23) ◽  
pp. 6338-6344 ◽  
Author(s):  
Jorge E. Galán

Salmonella Typhi is the cause of typhoid fever, a disease that has challenged humans throughout history and continues to be a major public health concern. Unlike infections with most other Salmonellae, which result in self-limiting gastroenteritis, typhoid fever is a life-threatening systemic disease. Furthermore, in contrast to most Salmonellae, which can infect a broad range of hosts, S. Typhi is a strict human pathogen. The unique features of S. Typhi pathogenesis and its stringent host specificity have been a long-standing puzzle. The discovery of typhoid toxin not only has provided major insight into these questions but also has offered unique opportunities to develop novel therapeutic and prevention strategies to combat typhoid fever.


1877 ◽  
Vol 3 (60supp) ◽  
pp. 957-957
Author(s):  
Alfred L. Loomis

Author(s):  
Katarzyna Pancer ◽  
Włodzimierz Gut

Clinical symptoms of tick-borne encephalitis (TBE) were first described in Poland in 1948 by Demiaszkiewicz. All patients had been living in the Białowieża region (in northeastern Poland). Similar infections were described to those that had been diagnosed in the same region before World War II as complicated cases of typhoid fever or influenza.


Sign in / Sign up

Export Citation Format

Share Document